Reprint

Cancer Prevention with Molecular Target Therapies 3.0

Edited by
June 2023
318 pages
  • ISBN978-3-0365-7909-2 (Hardback)
  • ISBN978-3-0365-7908-5 (PDF)

This book is a reprint of the Special Issue Cancer Prevention with Molecular Target Therapies 3.0 that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Personalized medicine is playing an important role in cancer prevention. To date, it is clear that many cancers are molecularly distinct subtypes, and different therapeutic approaches would be required for each. This Special Issue brings together original research and review articles on molecular oncology with attention to the early detection and prevention of cancer. It highlights new findings, methods, and technical advances in molecular cancer research. The main feature of this reprint was to provide an open-source sharing of significant works in the field of molecular oncology that can increase our understanding of cancer development. Topics include:Molecular methods to personalize cancer screening and detection;Molecular target therapies to prevent cancer development and metastases;Identification and new aspects of cellular signaling molecules and pathways for target discovery, drug design and personalized and gender medicine;Drug repurposing for cancer prevention;Molecular modeling studies.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
colorectal cancer; adenomas; array comparative genomic hybridization; long non-coding RNA; MALAT1; COVID-19; SARS-CoV-2; ketogenic diet; nutrition in pregnancy; microbiota; cancer; carcinoma; precision medicine; health promotion; metabolomics; amino acid restriction; glucose restriction; mass spectrometry; low carb; 2-deoxy-D-glucose; 2-DG; methionine; perfusion culture; energy restriction; caloric restriction; target discovery; epithelial–mesenchymal transition (EMT); RNA-binding protein 3 (RBMS3); carcinogenesis; target therapy; zinc fingers; homeoboxes; ZHX1; ZHX2; ZHX3; cancer; HCC; miR-221; astrocyte elevated gene-1; angiogenesis; cell proliferation; regulatory genes; α-catulin; CTNNAL1; catenin; invasion; epithelial-mesenchymal transition; EMT; vascular mimicry; statins; repurposed drugs; gynecological cancer; endometrial cancer; ovarian cancer; cervical cancer; NSCLC; BPR0C261; radiosensitivity; DNA damage; microtubule inhibitor; p53; PTEN; acridine-triazole; acridine-thiadiazole; topoisomerase I; anti-angiogenesis; zebrafish; neuroblastoma; ATRX; MYCN; ClpPX protease; ONC201; apoptosis; mitochondria; liquid biopsy; lung cancer; biomarkers; precision medicine; dysgeusia; dysosmia; taste; smell; cancer treatment; rapid review; glycolysis; cancer metabolism; combination therapy; Akt; anti-inflammatory action; COX-1; hydrazones; non-small cell lung cancer; thiosemicarbazides; gastric cancer; pepsinogen; gastrin G17; Helicobacter pylori; screening